These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7034415)

  • 1. [Antigenic characteristics of a preparation obtained by a non-destructive method from Shigella flexneri and Shigella sonnei].
    Gorbunova ES; Elkina SI; Mashiashvili IIa; Bespalova LA; Romanov VS
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):54-9. PubMed ID: 7034415
    [No Abstract]   [Full Text] [Related]  

  • 2. [The antigenic and immunogenic properties of the bivalent strain Shigella flexneri-Shigella sonnei 1 No. 200].
    Bondarenko VM; Nikolaeva AI; Marakusha BI; Belova TS
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):47-8. PubMed ID: 8553752
    [No Abstract]   [Full Text] [Related]  

  • 3. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
    Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations.
    Maggiore L; Yu L; Omasits U; Rossi O; Dougan G; Thomson NR; Saul A; Choudhary JS; Gerke C
    Int J Med Microbiol; 2016 Feb; 306(2):99-108. PubMed ID: 26746581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of pancrealysates of Sh. flexneri 2a and Sh. sonnei fractionated by filtration through Sephadex G-200 and ultracentrifugation].
    Kaverina KG; Shuvaeva LP; Zhvanetskaia MI; Rostovtseva NA; Kreinin LS
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jul; (7):51-6. PubMed ID: 795248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic relationship among virulent enteroinvasive Escherichia coli, Shigella flexneri, and Shigella sonnei detected by ELISA.
    Pál T; Pácsa S; Emödy L; Vörös S
    Lancet; 1983 Jul; 2(8341):102. PubMed ID: 6134933
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
    Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
    Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioprotective properties of Shigella antigens].
    Gorbunova ES; Mal'tsev VN; Tiurin EA
    Radiobiologiia; 1981; 21(4):591-4. PubMed ID: 7029609
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential Shigella flexneri 2a and Shigella sonnei I live vaccinal strains. Characterization of immunogenicity in animal models.
    Denchev V; Sumerska T; Marinova S; Vassilev T; Panova I; Linde K
    Acta Microbiol Hung; 1990; 37(4):359-66. PubMed ID: 2099082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical characteristics of Shigella sonnei and serotype 6 Shigella flexneri lipopolysaccharides and enterobacterial common antigen.
    Romanowska E; Katzenellenbogen E; Lugowski C; Gamian A; Bogulska M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):249-54. PubMed ID: 86336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the diagnostic effectiveness Shigella sonnei and Shigells flexneri antigenic preparations by serological examination data on patients with clinical dysentery].
    Nikitiuk NM; Sumarokov AA; Bardzilauskene AP; Mil'ner EM; Bodiu VI
    Zh Mikrobiol Epidemiol Immunobiol; 1978; (12):69-75. PubMed ID: 371292
    [No Abstract]   [Full Text] [Related]  

  • 13. [Liver and kidney function after immunization with an enteral vaccine from Shigella flexneri and Shigella sonnei antigens (blood biochemical test data)].
    Kreĭnin LS; Sergeev VV; Matchin VG; Domnikova AA; Elkina SI
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):67-9. PubMed ID: 7034416
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The antigenic structure of shigellae. 4. Isolation and purification of a thermolabile antigen of SH. sonnei].
    Seltmann G
    Zentralbl Bakteriol Orig A; 1972 Mar; 219(3):324-35. PubMed ID: 4122375
    [No Abstract]   [Full Text] [Related]  

  • 16. [Development and use of solid-phase test-systems for the detection of O-antigen of Shigella sonnei and Shigella flexneri].
    Triasuchev IO; Davydov AG; Burkin VS; Pokrovskiĭ VI; Pukhova TV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):74-7. PubMed ID: 2477970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolation and characteristics of Shigella antigens during the course of dysentery].
    Karal'nik BV; Nurkina NM
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jan; (1):49-52. PubMed ID: 3551415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract]   [Full Text] [Related]  

  • 20. Technological aspect of the production of live dysentery vaccines for oral administration.
    Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K
    Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.